A NUMBER of metals and some of their compounds have shown evidence of carcinogenic activity in the experimental animal and a brief review of these agents has been given by Roe and Lancaster (1964). One metal currently receiving attention in this respect has been cadmium. The repeated subcutaneous injection of ferritin in a group of rats was found to produce malignant tumours at the injection site, testicular atrophy and interstitial cell tumours of the testis (Haddow, Dukes and Mitchley, 1]961). The ferritin had been prepared from rat-liver protein by precipitation with a cadmium salt. Following this observation similar results were obtained in a group of rats given repeated injections of a soluble cadmium salt in the form of cadmium sulphate. (Haddow, Roe, Dukes and Mitchley, 1964;Roe, Dukes, Cameron, Pugh and Mitchley, 1964) Sarcomata at the injection site and testicular tumours were later reported following the single subcutaneous injection of a relatively small dose of cadmium chloride, another soluble compound (Gunn, Gould and Anderson, 1964). Finely divided cadmium metal suspended in serum and injected into the thigh muscle of the rat led to the production of rhabdomyosarcoma and fibrosarcoma in an experiment given in a preliminary report by Heath, Daniel, Dingle and Webb (1962), and described in detail by Heath and Daniel (1964). The insoluble compound cadmium sulphide has also been shown to give rise to sarcomata at the site of subcutaneous injection in the rat (Kazantzis, 1963). The results of this experiment, performed independently in 1961, together with the findings in a further series, are now given in detail. The induction of sarcomata at the site of subcutaneous injection of cadmium sulphide was confirmed, and similar tumours were shown to follow intramuscular injection. However, the intratracheal instillation of cadmium sulphide was not followed by the development of tumours, although there were other pathological changes which will be reported separately. In a further experiment a high incidence of tumours was obtained at the injection site following the subcutaneous injection of a suspension of cadmium oxide.
MATERIALS AND METHODWistar rats of the Chester Beatty strain were used. They were provided with water and with pellets of diet 41B (Medical Research Council) ad libitum. A standardised vitamin supplement was added, and the diet supplemented at intervals with liver, bread and milk. The animals were lightly anaesthetised with ether and the skin at the injection site was shaved and cleaned with spirit. A